Literature DB >> 16162559

E-prescribing and the medicare modernization act of 2003.

Douglas S Bell1, Maria A Friedman.   

Abstract

Provisions of the Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003 are intended to foster electronic prescribing by requiring standards for interoperability and by permitting third parties to offset implementation costs. Although physicians have been slow to embrace e-prescribing, adoption may increase in 2006, when a new tide of pharmacy messages will arrive from patients entering multi-tier drug coverage under Medicare. However, the e-prescribing systems selected may lack the advanced features needed to improve patient safety and chronic disease control. To optimize the return on Medicare drug spending, the government should consider additional incentives to spur the uptake of more advanced systems.

Entities:  

Mesh:

Year:  2005        PMID: 16162559     DOI: 10.1377/hlthaff.24.5.1159

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  18 in total

1.  Commentary on the federal government's role in influencing e-prescribing use and research.

Authors:  Olufunmilola K Odukoya; Michelle A Chui
Journal:  Perspect Health Inf Manag       Date:  2012-04-01

2.  E-Prescribing collaboration in Massachusetts: early experiences from regional prescribing projects.

Authors:  John Halamka; Meg Aranow; Carl Ascenzo; David W Bates; Kate Berry; Greg Debor; Jessica Fefferman; John Glaser; Jerilyn Heinold; John Stanley; Diane L Stone; Thomas E Sullivan; Micky Tripathi; Bruce Wilkinson
Journal:  J Am Med Inform Assoc       Date:  2006-02-24       Impact factor: 4.497

Review 3.  Barriers and facilitators to implementing electronic prescription: a systematic review of user groups' perceptions.

Authors:  Marie-Pierre Gagnon; Édith-Romy Nsangou; Julie Payne-Gagnon; Sonya Grenier; Claude Sicotte
Journal:  J Am Med Inform Assoc       Date:  2013-10-15       Impact factor: 4.497

4.  E-prescribing errors in community pharmacies: exploring consequences and contributing factors.

Authors:  Olufunmilola K Odukoya; Jamie A Stone; Michelle A Chui
Journal:  Int J Med Inform       Date:  2014-03-04       Impact factor: 4.046

5.  Variation in electronic prescribing implementation among twelve ambulatory practices.

Authors:  Jesse C Crosson; Nicole Isaacson; Debra Lancaster; Emily A McDonald; Anthony J Schueth; Barbara DiCicco-Bloom; Joshua L Newman; C Jason Wang; Douglas S Bell
Journal:  J Gen Intern Med       Date:  2008-04       Impact factor: 5.128

6.  Transitioning between electronic health records: effects on ambulatory prescribing safety.

Authors:  Erika L Abramson; Sameer Malhotra; Karen Fischer; Alison Edwards; Elizabeth R Pfoh; S Nena Osorio; Adam Cheriff; Rainu Kaushal
Journal:  J Gen Intern Med       Date:  2011-04-16       Impact factor: 5.128

7.  Electronic prescribing improves medication safety in community-based office practices.

Authors:  Rainu Kaushal; Lisa M Kern; Yolanda Barrón; Jill Quaresimo; Erika L Abramson
Journal:  J Gen Intern Med       Date:  2010-02-26       Impact factor: 5.128

8.  Meaningful use of electronic prescribing in 5 exemplar primary care practices.

Authors:  Jesse C Crosson; Rebecca S Etz; Shinyi Wu; Susan G Straus; David Eisenman; Douglas S Bell
Journal:  Ann Fam Med       Date:  2011 Sep-Oct       Impact factor: 5.166

9.  Evaluation of the NCPDP Structured and Codified Sig Format for e-prescriptions.

Authors:  Hangsheng Liu; Q Burkhart; Douglas S Bell
Journal:  J Am Med Inform Assoc       Date:  2011-05-25       Impact factor: 4.497

10.  Evaluating the technical adequacy of electronic prescribing standards: Results of an expert panel process.

Authors:  Douglas S Bell; Anthony J Schueth; John Paul Guinan; Shinyi Wu; Jesse C Crosson
Journal:  AMIA Annu Symp Proc       Date:  2008-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.